Literature DB >> 22215241

When is neuromyelitis optica diagnosed after disease onset?

Akiyuki Uzawa1, Masahiro Mori, Mayumi Muto, Saeko Masuda, Satoshi Kuwabara.   

Abstract

To diagnose neuromyelitis optica (NMO), the 2006 NMO diagnostic criteria is commonly used. However, adequate studies about the time course of NMO according to the criteria have been lacking. The aim of the study was to identify the interval between disease onset and diagnosis of NMO, as well as the clinical characteristics and time course, according to the 2006 NMO diagnostic criteria in Japanese patients with NMO. Clinical progression and time course of 43 Japanese patients with NMO who fulfilled the 2006 NMO diagnostic criteria with mean disease duration of 14.2 years were investigated retrospectively. The initial inflammatory event was myelitis in 44.2% (long extensive transverse myelitis [LETM] in 14.3%), optic neuritis in 41.9%, and concurrent myelitis and optic neuritis in 9.3% of the patients. The presence of LETM and anti-aquaporin-4 antibody seropositivity by the end of the observation period was found in 85.7 and 93.0% of the patients, respectively. Among the patients whose medical information were sufficiently available, the median intervals between NMO onset and the time until development of both optic neuritis and myelitis, LETM, or fulfillment of the 2006 NMO criteria were 16.5, 35.1, and 27.8 months, respectively. The development of diagnostic method at an early stage of NMO may be needed in order to initiate early treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22215241     DOI: 10.1007/s00415-011-6384-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6.

Authors:  Akiyuki Uzawa; Masahiro Mori; Kimihito Arai; Yasunori Sato; Sei Hayakawa; Saeko Masuda; Junko Taniguchi; Satoshi Kuwabara
Journal:  Mult Scler       Date:  2010-08-25       Impact factor: 6.312

2.  Neuromyelitis optica in France: a multicenter study of 125 patients.

Authors:  N Collongues; R Marignier; H Zéphir; C Papeix; F Blanc; C Ritleng; M Tchikviladzé; O Outteryck; S Vukusic; M Fleury; B Fontaine; D Brassat; M Clanet; M Milh; J Pelletier; B Audoin; A Ruet; C Lebrun-Frenay; E Thouvenot; W Camu; M Debouverie; A Créange; T Moreau; P Labauge; G Castelnovo; G Edan; E Le Page; G Defer; B Barroso; O Heinzlef; O Gout; D Rodriguez; S Wiertlewski; D Laplaud; F Borgel; P Tourniaire; J Grimaud; B Brochet; P Vermersch; C Confavreux; J de Seze
Journal:  Neurology       Date:  2010-03-02       Impact factor: 9.910

3.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

4.  Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

Authors:  Monika Bradl; Tatsuro Misu; Toshiyuki Takahashi; Mitsutoshi Watanabe; Simone Mader; Markus Reindl; Milena Adzemovic; Jan Bauer; Thomas Berger; Kazuo Fujihara; Yasuto Itoyama; Hans Lassmann
Journal:  Ann Neurol       Date:  2009-11       Impact factor: 10.422

5.  Relapsing neuromyelitis optica: long term history and clinical predictors of death.

Authors:  P Cabre; A González-Quevedo; M Bonnan; A Saiz; S Olindo; F Graus; D Smadja; H Merle; L Thomas; J A Cabrera-Gomez
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10       Impact factor: 10.154

6.  Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.

Authors:  Elisa Bizzoco; Francesco Lolli; Anna Maria Repice; Bahia Hakiki; Mario Falcini; Alessandro Barilaro; Rosanna Taiuti; Gianfranco Siracusa; Maria Pia Amato; Tiziana Biagioli; Silvia Lori; Marco Moretti; Annalisa Vinattieri; Patrizia Nencini; Luca Massacesi; Sabrina Matà
Journal:  J Neurol       Date:  2009-05-28       Impact factor: 4.849

7.  Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.

Authors:  Sei Hayakawa; Masahiro Mori; Akiko Okuta; Akiko Kamegawa; Yoshinori Fujiyoshi; Yasumasa Yoshiyama; Kaoru Mitsuoka; Kenichi Ishibashi; Sei Sasaki; Takamichi Hattori; Satoshi Kuwabara
Journal:  J Neuroimmunol       Date:  2008-05-06       Impact factor: 3.478

8.  The natural history of recurrent optic neuritis.

Authors:  Istvan Pirko; Lori A Blauwet; Lori K Blauwet; Timothy G Lesnick; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2004-09

9.  Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

Authors:  Samira Saadoun; Patrick Waters; B Anthony Bell; Angela Vincent; A S Verkman; Marios C Papadopoulos
Journal:  Brain       Date:  2010-01-04       Impact factor: 13.501

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

View more
  1 in total

Review 1.  Neuro-ophthalmology update.

Authors:  Konrad P Weber; Dominik Straumann
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.